"This bipartisan legislation will eliminate the pill penalty and help ensure science and researchers – not government bureaucrats – determine the possible treatments innovator companies pursue," said BIO CEO and president John Crowley.
US biotech industry welcomes proposed change to price negotiation power
February 27, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Immutep unveils dual breakthroughs at ESMO 2025, strengthening case for Efti across multiple tumour types
October 20, 2025 - - Australian Biotech -
Pharmac targets red tape to streamline access to some medicines and health consumables
October 20, 2025 - - Latest News -
Australia records worst flu season on record as vaccination rates stagnate
October 20, 2025 - - Latest News -
Merck expands commitment to first nations STEM leadership with new scholarships and partnerships
October 19, 2025 - - Latest News -
Orthocell boosts balance sheet with capital raise to drive nerve repair product growth
October 19, 2025 - - Australian Biotech -
Amplia targets US market expansion as FAK inhibitor shows promise in pancreatic cancer
October 19, 2025 - - Australian Biotech -
New combination therapy sets landmark survival benchmark in bladder cancer treatment
October 19, 2025 - - Latest News